PharmaBoardroom

Product Liability: Switzerland

Want to know more about product liability in Swiss Pharma? Read on! Prepared in association with Wenger Plattner, a leading law firm in Switzerland,…

Traditional Medicines and OTC Products: Switzerland

An intro to the legal situation for traditional medicines and OTC products in Swiss Pharma. Prepared in association with Wenger Plattner, a leading…

Marketing, Manufacturing, Packaging & Labeling Advertising:…

Marketing, manufacturing, packaging & labeling, advertising in Swiss Pharma - an overview. Prepared in association with Wenger Plattner, a leading…

Preclinical and Clinical Trial Requirements: Switzerland

Key legal info on preclinical and clinical trial requirements in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in…

Regulatory, Pricing and Reimbursement Overview: Switzerland

An insight into regulatory, pricing and reimbursement overview in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in…

Indian Pharma Manufacturing: Back in Business

COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and active pharmaceutical ingredients for…

Gerard Anderson – Professor, Johns Hopkins University…

Dr Gerard Anderson of Johns Hopkins University Bloomberg School of Public Health critiques the US response to the COVID-19 pandemic, before explaining…

Oncology in Morocco: Access Challenges & New Solutions

Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face…

Pharma Faces: Taher Hassen, Merck Morocco

Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year double-digit growth for the affiliate…

Company Spotlight: Iberma

Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding in 1994 to become the market leader…

COVID-19 Vaccine: Sanofi CEO Paul Hudson Commits to “Bring…

In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the US would get priority access to a…

Sanofi CEO Paul Hudson on GSK Vaccine Collaboration

In an interview with Financial Times correspondent Leila Abboud at the FT Global Boardroom video conference on the 14th of May, Paul Hudson, CEO of…

Tagged with A